Kraken Robotics Inc. (TSX Venture: PNG; OTCQB: KRKNF) closed at C$4.34 on October 21, 2026, about half the C$8.50 price institutions paid in March to help fund the Covelya Group acquisition. Sean Westropp of Deep Sail Capital named Kraken Robotics his favorite long near a 52-week low on October 22, arguing that the funds that crowded in have mostly cleared out. The next test is the Q3 2026 report, the first quarter to include Covelya.
This is journalism and commentary, not investment advice. We hold no position unless stated.
Key facts
- Ticker and exchange: Kraken Robotics Inc., PNG on the TSX Venture Exchange (KRKNF on OTCQB); prices in Canadian dollars.
- Situation type: a small-cap defense and subsea technology name down about 58% from its peak after a large, financed acquisition.
- The call: Deep Sail Capital (@DeepSailCapital) is long; on September 28, 2026 it said the stock was "very close to a bottom" and that it had added.
- Price: C$4.34 at the October 21, 2026 close, versus a closing high of C$10.23 on March 10, 2026 and a low close of C$3.98 on October 15 (Yahoo Finance).
- Size: about 370.9 million basic shares after the deal (company, July 2026), or roughly C$1.61 billion at C$4.34, by our math.
- Guidance: 2026 revenue of C$290 million to C$320 million and adjusted EBITDA of C$65 million to C$75 million, including about half a year of Covelya.
- Main risk: integration and execution on a deal that cost about C$615 million, about six times Kraken Robotics' 2025 revenue of C$102.2 million.
Is Kraken Robotics a good bet right now?
The bull case is that the selling was about positioning, not the business. Kraken Robotics kept its 2026 guidance after Q2, and announced 2026 orders reached C$355 million on a combined basis.
The bear case is that the stock has already broken once. Kraken Robotics posted Q2 results that were mixed against analyst estimates, booked a C$1.5 million revenue reversal and recorded a provision tied to a supplier arbitration. The real proof, a full quarter of Covelya, has not been reported yet.
Why are investors bullish on Kraken Robotics?
- A cheaper entry than the deal financing. Kraken Robotics sold 47,353,550 subscription receipts at C$8.50 on March 12, 2026 and issued Covelya's seller 15,882,352 shares at the same deemed price. The stock now trades 49% below that level.
- An earnings target. Westropp's September post said Kraken Robotics would earn C$0.20 a share in 2028, with revenue growing in the mid-20s to 30s percent. At C$4.34, that is about 21.7 times his 2028 estimate.
- Defense demand. Kraken Robotics sells sonar, subsea batteries and services. Its Q2 release added a long-term supply agreement for batteries with an unnamed maker of extra-large unmanned underwater vehicles.
- Synergies. The company expects about C$10 million of cost savings within 24 months and low-to-mid double-digit EPS accretion in 2027.
Who's making this call and why?
Sean Westropp runs Deep Sail Capital, a long/short growth and microcap fund, and posts as @DeepSailCapital. On September 28, 2026 he wrote that Kraken Robotics was "very close to a bottom" after a 60% drawdown, cited product ramps with Anduril, and said he had added more.
On October 22 he listed the stock first among his favorite longs near a 52-week low. In a reply, he called the slide "a long clearing event over the last 4 months" and said funds that loaded up near C$2 two years ago were "mostly past us."
Track record. In our tracking, Deep Sail Capital is 13-12 (a .520 win rate) on 25 calls scored at 180 days against the S&P 500, with an average edge of +8.9 percentage points, ranked 6th on the career table. Its longs are 4-8 and its last 10 scored calls went 2-8. Its worst scored call is this same stock: a March 3, 2026 Kraken Robotics long trailed the S&P 500 by 57.4 points. See the scoreboard.
Other supporters:
- Dutch investor Ehrmantraut Capital wrote on October 5, with the stock at C$4.33: "I'm still bullish on it."
- Independent small-cap researcher Anton (@Im_Specter) argued on September 9 that the Covelya merger opens a large maritime defense and energy market and that "The recent decline may be an opportunity."
Who disagrees?
Chart-focused trader PlotLine (@TradeTactician1) said on September 26 that Kraken Robotics was in "stage 4" of a market cycle and that buyers should wait for the price to flatten near the 200-week average, around $2. The stock has since traded near C$4.
Other risks from the filings:
- Execution. Q2 revenue rose only 4% to C$27.3 million, and 2026 revenue is weighted to the second half.
- Leverage. Kraken Robotics drew a new C$125 million term loan to close Covelya.
- Legal. The Q2 net loss of C$7.5 million included a provision for an arbitration over a 2017 supplier contract, per MarketWatch.
- Overhang. Holders who paid C$8.50 in March sit on large paper losses.
What are the key facts to verify?
- The Q2 2026 results release for revenue, the reversal, orders and guidance.
- The Covelya closing release for the price, the share issue and the C$125 million term loan.
- The March 12 offering release for the C$8.50 receipts.
- MarketWatch on the Q2 loss and arbitration provision.
What would prove it right or wrong?
Right: Q3 2026 shows strong combined revenue and margins, Kraken Robotics confirms the C$290 million to C$320 million guidance, and new defense orders arrive.
Wrong: guidance is cut, Covelya margins disappoint, the arbitration grows, or the stock keeps sliding toward the low levels chart traders are watching.
This is journalism and commentary, not investment advice. We hold no position unless stated.